Monoamine oxidase A gene polymorphism predicts adolescent outcome of attention‐deficit/hyperactivity disorder
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
ADHD is generally deemed to be a highly heritable disorder with mean heritability of 0.75. The enzyme monoamine oxidase (MAO), which has both A and B types, has long been considered a candidate pathological substrate for ADHD, and more recently, the genes for both MAO enzymes have been examined as mediators of the illness. Previous studies indicated that 30–50% of children with ADHD will experience symptoms that persist into adolescence and will have more significant impairment in social and neuropsychological functioning compared to those whose symptoms have remitted. Genes may also influence these characteristics of the disorder, and in this context MAO genes may also be candidates for moderating the presentation of ADHD. The current study examined the association between adolescent outcome of ADHD and MAO gene polymorphisms, including the 941T > G polymorphism in exon 8 (rs1799835) and 1460C > T polymorphism in exon 14 (rs1137070) of the MAOA gene, and the A > G polymorphism in intron13 (rs1799836), C > T polymorphism in the 3'UTR (rs1040399), and 2327T > C polymorphism in exon15 of the MAOB gene. Significant associations were observed between the MAOA gene polymorphisms and ADHD remission. Due to the small sample size and the possibility of phenotypic and etiologic heterogeneity of ADHD outcomes across ethnic or geographic groups, these results must be replicated before they can be generalized to other populations. © 2007 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular genetics of attention-deficit/hyperactivity disorder
Faraone, S. V., Perlis, R. H., Doyle, A. E., Smoller, J. W., Goralnick, J. J., Holmgren, M. A., & Sklar, P. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.024 · Cited by 2,357
Self-citationFARAONE, S. V., BIEDERMAN, J., & MICK, E. (2006) · Psychological Medicine · doi:10.1017/s003329170500471x · Cited by 2,267
Self-citationBARKLEY, R. A., FISCHER, M., EDELBROCK, C. S., & SMALLISH, L. (1990) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199007000-00007 · Cited by 1,507
Biederman, J. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.816 · Cited by 1,498 · cited 4×
“Functional remission therefore represents full recovery [Biederman et al., 2000], which our results suggest may have a stronger genetic foundation than other categories of remission.”
BackgroundInfluentialHyperactive Boys Almost Grown Up: I. Psychiatric Status
Gittelman, R. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790330017002 · Cited by 977
Hart, E. L., Lahey, B. B., Loeber, R., Applegate, B., & Frick, P. J. (1995) · Journal of Abnormal Child Psychology · doi:10.1007/bf01447474 · Cited by 590
Mechanism of action of methylphenidate: Insights from PET imaging studies
Volkow, N. D., Fowler, J. S., Wang, G., Ding, Y., & Gatley, S. J. (2002) · Journal of Attention Disorders · doi:10.1177/070674370200601s05 · Cited by 353 · cited 2×
“Evidence from pharmacologic studies [Volkow et al., 2002] and neuroimaging studies [Faraone, 2004a] suggest that Jun Li and Chuanyuan Kang contributed equally to this work.”
ResultHawi, Z., Dring, M., Kirley, A., Foley, D., Kent, L., Craddock, N., Asherson, P., Curran, S., Gould, A., Richards, S., et al. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001048 · Cited by 175 · cited 1×
“Molecular genetic studies have identified those coding for neurotransmitter receptors and enzymes, especially those in the dopamine, serotonin, and norepinephrine systems as the strongest candidate genes [Faraone et al., 2001; Hawi et al., 2002; Bobb et al., 2005].”
BackgroundGenetics of adult attention-deficit/hyperactivity disorder
Faraone, S. V. (2004) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(03)00090-x · Cited by 166
Self-citationKent, L., Doerry, U., Hardy, E., Parmar, R., Gingell, K., Hawi, Z., Kirley, A., Lowe, N., Fitzgerald, M., Gill, M., et al. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001100 · Cited by 153
Cited by
Lara, C., Fayyad, J., de Graaf, R., Kessler, R. C., Aguilar-Gaxiola, S., Angermeyer, M., Demytteneare, K., de Girolamo, G., Haro, J. M., Jin, R., et al. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.10.005 · Cited by 420
Molecular genetics of attention-deficit/hyperactivity disorder: an overview
Banaschewski, T., Becker, K., Scherag, S., Franke, B., & Coghill, D. (2010) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-010-0090-z · Cited by 252
“While it may still be possible that variations in the MAOA gene are associated with persistence of ADHD into adolescence [100] and play a role in the variation in neuropsychological performance [149], Thapar et al.”
BackgroundNilsen, F. M., & Tulve, N. S. (2020) · Environmental Research · doi:10.1016/j.envres.2019.108884 · Cited by 78
Achieving Remission as a Routine Goal of Pharmacotherapy in Attention-Deficit Hyperactivity Disorder
Ramos-Quiroga, J. A., & Casas, M. (2011) · CNS Drugs · doi:10.2165/11538450-000000000-00000 · Cited by 33
Metadata
- Authors
- Li, J., Kang, C., Zhang, H., Wang, Y., Zhou, R., Wang, B., Guan, L., Yang, L., & Faraone, S. V.
- Venue
- American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Publisher
- Wiley
- Published
- 2007-04-10
- Volume
- 144B
- Issue
- 4
- Pages
- 430-433
- ISSN
- 1552-4841 (ISSN-L)
- 1552-485X
- OpenAlex
- W2012815005
- Cited by
- 42
- References
- 12
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Monoamine oxidase A gene polymorphism predicts adolescent outcome of attention‐deficit/hyperactivity disorder. https://app.cochat.ai/papers/10.1002/ajmg.b.30421
- The paper
- Li, J., Kang, C., Zhang, H., Wang, Y., Zhou, R., Wang, B., Guan, L., Yang, L., & Faraone, S. V. (2007). Monoamine oxidase A gene polymorphism predicts adolescent outcome of attention‐deficit/hyperactivity disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. https://doi.org/10.1002/ajmg.b.30421
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.